Treatment of venous thromboembolism using only low-molecular-weight heparin?
White
R H
RH
D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D004305:Dose-Response Relationship, Drug; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D006801:Humans; D007279:Injections, Subcutaneous; D015201:Meta-Analysis as Topic; D012107:Research Design; D055502:Secondary Prevention; D013810:Therapeutic Equivalency; D013923:Thromboembolism / Q000191:economics / Q000517:prevention & control*; D014481:United States; D014859:Warfarin / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D014859:Warfarin